IBDEI0YA ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15795,1,3,0)
 ;;=3^Calculus of Kidney w/ Calculus of Ureter
 ;;^UTILITY(U,$J,358.3,15795,1,4,0)
 ;;=4^N20.2
 ;;^UTILITY(U,$J,358.3,15795,2)
 ;;=^5015609
 ;;^UTILITY(U,$J,358.3,15796,0)
 ;;=N32.0^^85^826^3
 ;;^UTILITY(U,$J,358.3,15796,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15796,1,3,0)
 ;;=3^Bladder-Neck Obstruction
 ;;^UTILITY(U,$J,358.3,15796,1,4,0)
 ;;=4^N32.0
 ;;^UTILITY(U,$J,358.3,15796,2)
 ;;=^5015649
 ;;^UTILITY(U,$J,358.3,15797,0)
 ;;=N31.1^^85^826^33
 ;;^UTILITY(U,$J,358.3,15797,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15797,1,3,0)
 ;;=3^Reflex Neuropathic Bladder NEC
 ;;^UTILITY(U,$J,358.3,15797,1,4,0)
 ;;=4^N31.1
 ;;^UTILITY(U,$J,358.3,15797,2)
 ;;=^5015645
 ;;^UTILITY(U,$J,358.3,15798,0)
 ;;=N31.9^^85^826^29
 ;;^UTILITY(U,$J,358.3,15798,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15798,1,3,0)
 ;;=3^Neuromuscular Dysfunction of Bladder,Unspec
 ;;^UTILITY(U,$J,358.3,15798,1,4,0)
 ;;=4^N31.9
 ;;^UTILITY(U,$J,358.3,15798,2)
 ;;=^5015648
 ;;^UTILITY(U,$J,358.3,15799,0)
 ;;=N31.0^^85^826^36
 ;;^UTILITY(U,$J,358.3,15799,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15799,1,3,0)
 ;;=3^Uninhibited Neuropathic Bladder NEC
 ;;^UTILITY(U,$J,358.3,15799,1,4,0)
 ;;=4^N31.0
 ;;^UTILITY(U,$J,358.3,15799,2)
 ;;=^5015644
 ;;^UTILITY(U,$J,358.3,15800,0)
 ;;=N35.9^^85^826^37
 ;;^UTILITY(U,$J,358.3,15800,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15800,1,3,0)
 ;;=3^Urethral Stricture,Unspec
 ;;^UTILITY(U,$J,358.3,15800,1,4,0)
 ;;=4^N35.9
 ;;^UTILITY(U,$J,358.3,15800,2)
 ;;=^5015671
 ;;^UTILITY(U,$J,358.3,15801,0)
 ;;=N39.0^^85^826^35
 ;;^UTILITY(U,$J,358.3,15801,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15801,1,3,0)
 ;;=3^UTI,Unspec Site
 ;;^UTILITY(U,$J,358.3,15801,1,4,0)
 ;;=4^N39.0
 ;;^UTILITY(U,$J,358.3,15801,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,15802,0)
 ;;=R31.9^^85^826^21
 ;;^UTILITY(U,$J,358.3,15802,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15802,1,3,0)
 ;;=3^Hematuria,Unspec
 ;;^UTILITY(U,$J,358.3,15802,1,4,0)
 ;;=4^R31.9
 ;;^UTILITY(U,$J,358.3,15802,2)
 ;;=^5019328
 ;;^UTILITY(U,$J,358.3,15803,0)
 ;;=R31.0^^85^826^20
 ;;^UTILITY(U,$J,358.3,15803,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15803,1,3,0)
 ;;=3^Gross Hematuria
 ;;^UTILITY(U,$J,358.3,15803,1,4,0)
 ;;=4^R31.0
 ;;^UTILITY(U,$J,358.3,15803,2)
 ;;=^5019325
 ;;^UTILITY(U,$J,358.3,15804,0)
 ;;=R31.1^^85^826^1
 ;;^UTILITY(U,$J,358.3,15804,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15804,1,3,0)
 ;;=3^Benign Essential Microscopic Hematuria
 ;;^UTILITY(U,$J,358.3,15804,1,4,0)
 ;;=4^R31.1
 ;;^UTILITY(U,$J,358.3,15804,2)
 ;;=^5019326
 ;;^UTILITY(U,$J,358.3,15805,0)
 ;;=R31.2^^85^826^28
 ;;^UTILITY(U,$J,358.3,15805,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15805,1,3,0)
 ;;=3^Microscopic Hematuria NEC
 ;;^UTILITY(U,$J,358.3,15805,1,4,0)
 ;;=4^R31.2
 ;;^UTILITY(U,$J,358.3,15805,2)
 ;;=^5019327
 ;;^UTILITY(U,$J,358.3,15806,0)
 ;;=N40.0^^85^826^6
 ;;^UTILITY(U,$J,358.3,15806,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15806,1,3,0)
 ;;=3^Enlarged Prostate w/o Lower Urinary Tract Symptoms
 ;;^UTILITY(U,$J,358.3,15806,1,4,0)
 ;;=4^N40.0
 ;;^UTILITY(U,$J,358.3,15806,2)
 ;;=^5015689
 ;;^UTILITY(U,$J,358.3,15807,0)
 ;;=N42.89^^85^826^32
 ;;^UTILITY(U,$J,358.3,15807,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15807,1,3,0)
 ;;=3^Prostate Disorders NEC
 ;;^UTILITY(U,$J,358.3,15807,1,4,0)
 ;;=4^N42.89
 ;;^UTILITY(U,$J,358.3,15807,2)
 ;;=^270425
 ;;^UTILITY(U,$J,358.3,15808,0)
 ;;=N41.9^^85^826^23
 ;;^UTILITY(U,$J,358.3,15808,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15808,1,3,0)
 ;;=3^Inflammatory Disease of Prostate,Unspec
